Effect of Probiotic Supplementation on Gut Microbiota in Children with Autism: A Pilot Randomised Controlled Trial
Nutrients · 25.06.2026 · 18 (13) · 2079
DOI: 10.3390/nu18132079 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 25.06.2026. Verfasst von Sachin Agrawal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Neonatal Directorate, King Edward Memorial Hospital for Women, Perth, WA 6008, Australia. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Dietary Supplements, Gastrointestinal Microbiome, Probiotics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Perth children hospital foundation, Perth Children’s Hospital Foundation.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Dysbiosis of the gut microbiota is common in children with autism spectrum disorder (ASD). Probiotics have the potential to improve outcomes in ASD by modulating the gut microbiota–brain axis.
Methods
In a pilot randomised trial, children (2 to 5 years) with confirmed ASD (DSM-5 criteria) received either a multi-strain probiotic (450 billion CFU twice daily for one month, followed by once daily for three months) or placebo supplementation. Faecal microbiota profiles were assessed using pre- and post-supplementation samples. The primary outcome involved changes in gut microbiota diversity. Secondary outcomes included faecal short-chain fatty acid levels and behavioural changes.
Results
Difficulties in recruitment and loss to follow-up for reasons including COVID-19 resulted in the enrolment of only 23 (probiotic: 9; placebo: 14) instead of the planned 40 children. There was no evidence of changes in the gut microbiota in probiotic-supplemented children. The common phyla were Bacillota_A (~50%), Bacteroidota (~18%) and Actinobacteriota (~10%). Alpha- and Beta-diversity showed no significant difference between pre- vs. post-supplementation samples. Bifodobacteriaceae increased significantly in the probiotic-supplemented group (p = 0.046).
Conclusions
The increase in faecal Bifodobacteriaceae supports an evaluation of probiotics in ASD. Addressing the reasons for loss to follow-up is important when designing trials in this field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neonatal Directorate, King Edward Memorial Hospital for Women, Perth, WA 6008, Australia.
- School of Medicine, The University of Western Australia, Perth, WA 6009, Australia.
- Perth Children's Hospital, Perth, WA 6009, Australia.
- The Kids Research Institute Australia, Nedlands, WA 6009, Australia.
- UWA Centre for Child Health Research, The University of Western Australia, Perth, WA 6009, Australia.
- Fremantle Child Development Service, Perth, WA 6163, Australia.
ORCID-Profile: Torsten Thomas, Sanjay Patole
Förderung
- Perth children hospital foundation
- Perth Children’s Hospital Foundation
Zitieren
APA
Agrawal, S., Rao, S., Whitehouse, A., Alvares, G. A., Kulkarni, A., Taylor, J. A., Conway, P. L., Thomas, T., & Patole, S. (2026). Effect of Probiotic Supplementation on Gut Microbiota in Children with Autism: A Pilot Randomised Controlled Trial. Nutrients, 18(13), 2079. https://doi.org/10.3390/nu18132079
Vancouver
Agrawal S, Rao S, Whitehouse A, Alvares GA, Kulkarni A, Taylor JA, et al. Effect of Probiotic Supplementation on Gut Microbiota in Children with Autism: A Pilot Randomised Controlled Trial. Nutrients. 2026;18(13):2079. doi:10.3390/nu18132079
BibTeX
@article{Agrawal2026,
author = {Agrawal, Sachin and Rao, Shripada and Whitehouse, Andrew and Alvares, Gail A and Kulkarni, Alpana and Taylor, Jessica A and Conway, Patricia L and Thomas, Torsten and Patole, Sanjay},
title = {Effect of Probiotic Supplementation on Gut Microbiota in Children with Autism: A Pilot Randomised Controlled Trial},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {13},
pages = {2079},
doi = {10.3390/nu18132079}
}
EUVIMED